Director
DIN: 10447106
Gunjan Srivastava is currently associated with 2 companies in various capacities such as Director and Non- Individual Subscriber. They serve as a Director at SUDGUN HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10447106.Gunjan Srivastava is currently involved in 2 different roles. Their most recent position is with DHANAROGYAM HEALTH CARE PRIVATE LIMITED as a Non- Individual Subscriber. The first company Gunjan Srivastava was appointed to as a director was SUDGUN HEALTHCARE PRIVATE LIMITED. Gunjan Srivastava is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Gunjan Srivastava is currently associated with 2 companies in various capacities such as Director and Non- Individual Subscriber. They serve as a Director at SUDGUN HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10447106.Gunjan Srivastava is currently involved in 2 different roles. Their most recent position is with DHANAROGYAM HEALTH CARE PRIVATE LIMITED as a Non- Individual Subscriber. The first company Gunjan Srivastava was appointed to as a director was SUDGUN HEALTHCARE PRIVATE LIMITED. Gunjan Srivastava is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
7 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SUDGUN HEALTHCARE PRIVATE LIMITED | Director | 30-Dec-2023 |
| DHANAROGYAM HEALTH CARE PRIVATE LIMITED | Non- Individual Subscriber | 18-Feb-2025 |
| DHANAROGYAM HEALTH CARE PRIVATE LIMITED | Director | 18-Feb-2025 |